Follow us on Twitter
twitter icon@FreshPatents

Indole patents

Bulk PDF Downloads
      

This page is updated frequently with new Indole-related patent applications.




 Conjugate comprising folic acid and indole-3-carbinol for medical use patent thumbnailConjugate comprising folic acid and indole-3-carbinol for medical use
Conjugates of indole-3-carbinol are described for medical use and, particularly, for the prevention and treatment of neoplastic, inflammatory, cardiovascular diseases and other diseases, and of the metabolic syndrome.. .
Dom Terry International S.r.l.


 Oxindole inhibitors of tyrosine kinase patent thumbnailOxindole inhibitors of tyrosine kinase
The present invention relates to new oxindole inhibitors of tyrosine kinase, pharmaceutical compositions thereof, and methods of use thereof.. .
Auspex Pharmaceuticals, Inc.


 Anti-proprotein convertase subtilisin kexin type 9 (anti-pcsk9) compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseases patent thumbnailAnti-proprotein convertase subtilisin kexin type 9 (anti-pcsk9) compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseases
Disclosed are compounds that modulate the physiological action of the proprotein convertase subtilisin kexin type 9 (pcsk9), as well as therapeutic methods for use of such compounds to reduce ldl-cholesterol levels and/or for the treatment and/or prevention of cardiovascular disease (cvd), including treatment of hypercholesterolemia. Examples of compounds include thiadiazole, isoxazole, 1,2,4-triazole, thiazole, indole, pyrazole, and pyrrolinone derivatives..
Shifa Biomedical Corporation


 Benzopyridoindole derivative and organic electroluminescent element patent thumbnailBenzopyridoindole derivative and organic electroluminescent element
According to the present invention, there are provided a benzopyridoindole derivative represented by the following general formula (1); and an organic el element including a pair of electrodes and at least one organic layer sandwiched therebetween, wherein the above derivative is used as a constituent material for the at least one organic layer. The benzopyridoindole derivative of the present invention is excellent in electron injection/transport performance, has hole blocking capability, is highly stable in a thin film state, and excels in various characteristics.
Hodogaya Chemical Co., Ltd.


 Copolyesterimides derived from aromatic dicarboxylic acids and aliphatic glycols and films made therefrom patent thumbnailCopolyesterimides derived from aromatic dicarboxylic acids and aliphatic glycols and films made therefrom
A film comprising a copolyester wherein said copolyester comprises repeating units derived from an aliphatic glycol, an aromatic dicarboxylic acid, and a comonomer (m) selected from the group consisting of n,n′-bis-(2-hydroxyalkyl)-bicyclo-[2,2,2]-oct-7-ene-2,3,5,6-tetracarboxylic diimide (bodi) and 2-hydroxyalkyl-2-[p-(2-hydroxyethoxycarbonyl)phenyl]-1,3-dioxo-2h-isoindole-5-carboxylate (doic), wherein the number of carbon atoms is the 2-hydroxyalkyl group is 2, 3 or 4, and wherein comonomer (m) constitutes a proportion of the glycol fraction of the copolyester.. .
Dupont Teijin Films U.s. Limited Partnership


 Azaindoles as respiratory syncytial virus antiviral agents patent thumbnailAzaindoles as respiratory syncytial virus antiviral agents
Compositions containing these compounds as active ingredient and processes for preparing these compounds and compositions.. .

 Hydrazinyl-indole compounds and methods for producing a conjugate patent thumbnailHydrazinyl-indole compounds and methods for producing a conjugate
The present disclosure provides conjugate structures (e.g., polypeptide conjugates) and hydrazinyl-indole compounds used to produce these conjugates. The disclosure also provides methods of production of such conjugates, as well as methods of using the same..
Redwood Bioscience, Inc.


 Formulations of azaindole compounds patent thumbnailFormulations of azaindole compounds
A pharmaceutical composition comprises: a) 5 wt % to 95 wt % of a hcl salt of compound (1).xh2o by the weight of the pharmaceutical composition, wherein x is from 0 to 3; and b) 5 wt % to 95 wt % of a filler by the weight of the pharmaceutical composition. Another pharmaceutical composition comprises: a) 1 mg/ml to 20 mg/ml of compound (1) in water; and b) 0.01 m to 0.1 m of a pharmaceutically acceptable ph modifier.
Vertex Pharmaceuticals Incorporated


 Crystals of dispiropyrrolidine derivatives patent thumbnailCrystals of dispiropyrrolidine derivatives
Crystals of a dispiropyrrolidine compound or a salt thereof which inhibits the action of mdm2 are provided. The present invention provides crystals of (3′r,4′s,5′r)-n-[(3r,6s)-6-carbamoyltetrahydro-2h-pyran-3-yl]-6″-chloro-4′-(2-chloro-3-fluoropyridin-4-yl)-4,4-dimethyl-2″-oxo-1″,2″-dihydrodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indole]-5′-carboxamide or a salt thereof which inhibits mdm2 and has anti-tumor activity.
Daiichi Sankyo Company, Limited


 4-azaindole derivatives patent thumbnail4-azaindole derivatives
4-azaindole derivatives which are modulators of muscarinic acetylcholine receptor (machr) m1 and which may be effective for the prevention or disease modifying or symptomatic treatment of cognitive deficits associated with neurological disorders such as alzheimer-type dementia (ad) or dementia with lewy bodies (dlb), and a pharmaceutical composition comprising a 4-azaindole derivative as an active ingredient.. .
Eisai R&d Management Co., Ltd.


Indoles as respiratory syncytial virus antiviral agents


The prodrugs, n-oxides, addition salts, quaternary amines, metal complexes and stereochemically isomeric forms thereof; compositions containing these compounds as active ingredient and processes for preparing these compounds and compositions.. .

Breast cancer cell growth-inhibiting enzyme inhibitors, the production thereof, and use thereof


Novel enzyme inhibitors for treatment of breast cancer combine the inhibition of enzymes that combat aggressive breast cell growth both synergistically and additively. Pyrido-annulated indoles developed act in a selectively inhibiting manner on the enzymes her2 and/or brk in the nanomolar to picomolar concentration range in screening more than 200 kinases of the human kinome.
Martin-luther-universitÄt Halle-wittenberg


Thieno[2,3-e]indole derivatives as new antitumor agents


The present invention relates to a novel class of alkylating agents comprising a thieno[2,3-e]indole moiety tethered to a dna-binding moiety, which have cytotoxic activity and are useful in treating diseases such as cancer, cellular proliferation disorders and viral infections. The present invention also provides methods for preparing these compounds, pharmaceutical compositions comprising them and methods of treating diseases utilizing such compounds or the pharmaceutical composition containing them.
Nerviano Medical Sciences S.r.l.


Novel aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection


Wherein r1, r2, r3, r4, w and x are as described herein, compositions including the compounds and methods of using the compounds.. .

Methods of treating postherpetic neuralgia with a topical formulation of a spiro-oxindole compound


Are disclosed. The methods provide excellent penetration of the spiro-oxindole compound into the affected skin area to effectively reduce the severity of the postherpetic neuralgia and/or to alleviate the postherpetic neuralgia with minimal or negligible systemic exposure of the spiro-oxindole compound..

S-enantiomer of tetracyclic indole derivative as pbr ligands


The present invention concerns in vivo imaging and in particular in vivo imaging of translocator protein (tspo, formerly known as the peripheral benzodiazepine receptor). An indole-based in vivo imaging agent is provided that overcomes problems relating to known tspo-binding radiotracers.
Ge Healthcare Limited


Pyrimido[4,5-b]indole derivatives and use thereof in the expansion of hematopoietic stem cells


Pyrimido[4,5-b]indole derivatives are provided. These compounds are useful to expand hematopoietic stem cell populations, particularly, human hematopoietic stem cell populations.
UniversitÉ De MontrÉal


Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor


The present application is directed to processes and intermediates for making 4-({2-[(aminosulfonyl)amino]ethyl}amino)-n-(3-bromo-4-fluorophenyl)-n′-hydroxy-1,2,5-oxadiazole-3-carboximidamide, which is an inhibitor of indoleamine 2,3-dioxygenase, useful in the treatment of cancer and other disorders.. .
Incyte Holdings Corporation


Sulfonylindole derivatives and preparing the same


Disclosed are a sulfonylindole derivative useful for the prevention or treatment of pepetic ulcer, gastritis or reflux esophagitis, a method of preparing the same, and a pharmaceutical composition containing the same.. .
Daewoong Pharmaceutical Co., Ltd.


Order a batch download of a huge number of patent PDFs. Bulk PDF Downloads This is a premium service.

Pyridazinoindole compounds and methods for pet imaging


Embodiments of the invention include a novel synthesis of the translocator protein (tspo) ligands, and methods of imaging a molecular events. Also disclosed are compounds for treatment of diseases, including cancer..
Vanderbilt University


1,2,5-oxadiazoles as inhibitors of indoleamine 2,3- dioxygenase


The present invention is directed to 1,2,5-oxadiazole derivatives, and compositions of the same, which are inhibitors of indoleamine 2,3-dioxygenase and are useful in the treatment of cancer and other disorders, and to the processes and intermediates for making such 1,2,5-oxadiazole derivatives.. .
Incyte Holdings Corporation


Indole derivatives and process for their preparation


Are potent inhibitors of abeta peptide polymerization and can be used for the treatment of e.g. Alzheimers disease or ocular disorders..

Inhibitor of breast cancer resistance protein (bcrp)


Disclosed are compounds that inhibit breast cancer resistance protein (bcrp), of which compound (i-1), ((3s, 6s, 12as)-6-isobutyl-9-methoxy-3-methyl-2,3,6,7, 12, 12a- hexahydropyrazino[1′,2′: 1,6]pyrido[3,4-b]indole-1,4-dione) or a pharmaceutically acceptable salt thereof, and the compound 12, ((3s,6s,12as)-6-isobutyl-9-methoxy-3,10- dimethyl-2,3,6,7,12, 12a-hexahydropyrazino[1′,2′: 1,6]pyrido[3,4- b] indole-1,4-dione) or a pharmaceutically acceptable salt thereof. Also disclosed are methods of inhibiting bcrp or decreasing bcrp activity and methods of determining potential bcrp substrates..
Millennium Pharmaceuticals, Inc.


Radiosynthesis of tau radiopharmaceuticals


This disclosure relates to a one-step method for preparing the tau radiopharmaceutical, [18f]t807, using an unprotected or protected precursor (e.g., tert-butyl 7-(6-nitropyridin-3-yl)-5h-pyrido[4,3-b]indole-5-carboxylate).. .
The General Hospital Corporation


Carbazole compounds for in vivo imaging


The present invention concerns in vivo imaging and in particular in vivo imaging of translocator protein (tspo, formerly known as the peripheral benzodiazepine receptor). An indole-based in vivo imaging agent is provided that overcomes problems relating to known tspo-binding radiotracers.
Ge Healthcare Limited


Substituted indole mcl-1 inhibitors


The present application, among other things, provides compounds that are capable of inhibiting the activity of anti-apoptotic bcl-2 family proteins, for example, myeloid cell leukemia-1 (mcl-1) protein. The present invention also provides pharmaceutical compositions as well as methods for using provided compounds for treatment of diseases and conditions (e.g., cancer) characterized by the over-expression or dysregulation of mcl-1 protein.
Vanderbilt University


Compositions and methods for treating mitochondrial diseases


The invention described herein relates to methods for treating mitochondrial diseases. In particular, the invention relates to methods for treating mitochondrial diseases by administering therapeutically effective amounts of one or more tetracyclic pyrazinoindoles, and/or pharmaceutically acceptable salts thereof..
Biovista, Inc.


Indole-3-aldehyde for treating dysreactive immune disorders


The therapeutic use of bacteria, specifically but not only lactobacilli, which produce indole-3-aldehyde, or directly of indole-3-aldehyde itself, is proposed as a means of prevention and treatment of immune dysreactive disorders in which the hyper-inflammatory or autoimmune component represents the basic element. .
Universita' Degli Studi Di Perugia


Indole compound as inhibitor of necrosis


The present invention relates to an indole compound represented by formula (1), a pharmaceutically acceptable salt or isomer thereof, a composition for prevention or treatment of necrosis and necrosis-associated diseases, and a method for preparing the composition, the composition comprising the indole compound or the pharmaceutically acceptable salt or isomer thereof as an active ingredient.. .
Lg Life Sciences Ltd.


Ido inhibitors


There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (ido), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or autoimmune diseases utilizing the compounds of the invention.. .
Bristol-myers Squibb Company


Method for producing spirooxindole derivative


The present invention is intended to provide a method for efficiently producing and providing a compound having a spirooxindole skeleton, for example, a compound having a spirooxindole skeleton and having antitumor activity that inhibits the interaction between mdm2 protein and p53 protein, or an intermediate thereof, using an asymmetric catalyst. A compound having an optically active tricyclic dispiroindole skeleton is efficiently obtained through a catalytic asymmetric 1,3-dipolar cycloaddition reaction using ketimine as a reaction substrate and using a chiral ligand and a lewis acid..
Daiichi Sankyo Company, Limited


Indole amide compound as inhibitor of necrosis


The present invention relates to an indole amide compound represented by formula (1), a pharmaceutically acceptable salt or isomer thereof, a composition for prevention or treatment of necrosis and necrosis-associated diseases, and a method for preparing the composition, the composition comprising the indole compound or the pharmaceutically acceptable salt or isomer thereof as an active ingredient.. .
Lg Life Sciences Ltd.


Conjugate of benzofuranone and indole or azaindole, and preparation and uses thereof


The present invention relates to an oxo indirubin or isoindigo derivative, an oxo aza indirubin or isoindigo derivative, and their optical isomers, racemes, cis/trans isomers and pharmaceutically acceptable salts, which can be used for preparing a drug for treating or preventing diseases such as glucose metabolic disorder, inflammatory or autoimmune disease, neurodegenerative disease, a mental illness, tissue proliferation disease or tumors.. .

Indole derivatives as modulators of methyl modifying enzymes, compositions and uses thereof


Agents of formulas (i)/(ii)/(iii) for modulating methyl modifying enzymes, compositions and uses thereof are provided herein.. .

Indole-carboxamides


The compounds may be used for the treatment of schizophrenia, obsessive-compulsive personality disorder, major depression, bipolar disorders, anxiety disorders, normal aging, epilepsy, retinal degeneration, traumatic brain injury, spinal cord injury, post-traumatic stress disorder, panic disorder, parkinson's disease, dementia, alzheimer's disease, cognitive impairment, chemotherapy-induced cognitive dysfunction (“chemobrain”), down syndrome, autism spectrum disorders, hearing loss, tinnitus, spinocerebellar ataxia, amyotrophic lateral sclerosis, multiple sclerosis, huntington's disease, stroke, and disturbances due to radiation therapy, chronic stress, or abuse of neuro-active drugs, selected from alcohol, opiates, methamphetamine, phencyclidine and cocaine.. .

Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof


And stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, and with the substituents and structural features described herein. Also described are pharmaceutical compositions and medicaments that include the formula i compounds, as well as methods of using such estrogen receptor modulators, alone and in combination with other therapeutic agents, for treating diseases or conditions that are mediated or dependent upon estrogen receptors..

Derivatives of collagen-binding hairpin peptides


Compounds of interest, for example active pharmaceutical ingredients, probes or inactive carriers, may be delivered to a site of interest by conjugating the compound of interest to a collagen-binding linear hairpin (cblh) peptide to form a molecule of formula (i) and then providing the molecule to the site of interest where the cblh peptide binds to collagen at the site of interest thereby delivering the compound of interest to the site of interest. Molecule of formula (i) are: (i) where: y is a first compound of interest; z is a second compound of interest; n and m are independently 0 or 1 with the proviso that at least one of n and m is 1; and, cblh is a collagen-binding linear hairpin peptide having 19 or fewer amino acids and having a turn amino acid sequence comprising 4 to 6 amino acid residues providing a stable turn structure, the turn sequence flanked on one side by a first flanking sequence having a wt(w/y) motif and flanked on the other side by a rr second flanking sequence having a wt(w/r) motif, the w residue at position 1 of the first flanking sequence forming a cross-strand indole-indole or cation-π interaction pair with the amino acid residue at position 3 of the second flanking sequence without any disulfide bond..
National Research Council Of Canada


Isotopically enriched azaindoles


The present invention relates to deuterated compounds that are useful for inhibiting janus kinases and processes and intermediates useful for preparing such compounds.. .
Vertex Pharmaceuticals Incorporated



The present invention relates to novel substituted oxindole derivatives, pharmaceutical compositions comprising them, and their use for the treatment of vasopressin-related disorders.. .
Abbvie Deutschland Gmbh & Co. Kg


Order a batch download of a huge number of patent PDFs. Bulk PDF Downloads This is a premium service.

Enantiomeric separation and purification of 2,3,4,9-tetrahydro-1h-carbazole-4-carboxylic acid amide derivatives


A method for the purification of cyclic indole compounds that provides advantages over previously-known methods. Using the method of the present invention allows for the facile preparation of a good quality solid form of these compounds..
Ge Healthcare Limited


Novel indole derivatives and their use in neurodegenerative diseases


The present invention relates to indole compounds, and pharmaceutically acceptable compositions thereof, useful as antagonists of p2x7, and for the treatment of p2x7-related disorders.. .
Merck Patent Gmbh


(1-azinone)-substituted pyridoindoles


Wherein r1 is h or optionally substituted alkyl; r2, r3, r4 are each independently selected from h, —o-alkyl, —s-alkyl, alkyl, halo, —cf3, and —cn; g is —cr12r13—nr5— or —nr5—cr12r13; r5 is h, optionally substituted alkyl, optionally substituted heterocycle, —c(═o)—r6, —c(═o)—o—r7, or —c(═o)—nr19r20; r6 and r7 are each optionally substituted alkyl or optionally substituted heterocycle; r8, r9, r10, r11, r12, r13, r19 and r20 are each independently selected from h or optionally substituted alkyl; r14 and r15 are each independently h or halogen; l is —ch2—o—, —ch2ch2—, —ch═ch— or a bond; and b is aryl or heteroaryl or cycloalkyl; with the proviso that, when l is a direct bond, b cannot be unsubstituted heteroaryl or heteroaryl monosubstituted with fluorine.. .

Novel aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection


Wherein r1, r2, r3, r4, r5, w and x are as described herein, compositions including the compounds and methods of using the compounds.. .

Cis-tetrahydro-spiro(cyclohexane-1, 1' -pyrido[3,4-b]indole)-4-amine compounds


Cis-tetrahydro-spiro(cyclohexane-1,1′-pyrido[3,4-b]indole)-4-amine compounds which act on the nociceptin/orl-1 receptor system as well as on the μ-opioid receptor system and which are distinguished in particular by selective effectiveness in the treatment of chronic pain, such as inflammatory pain, visceral pain, tumour pain, and neuropathic pain, without at the same time developing pronounced effectiveness against acute, nociceptive pain.. .
Gruenenthal Gmbh


Indole-3-carbinol derivatives


The present invention relates to novel stable indole-3-carbinol derivatives of formula-i and its pharmaceutical composition and biological activity. The present invention includes compositions and methods for the treatment and prevention of conditions associated with inflammation..
Cadila Pharmaceuticals Limited


Conjugated polymers


The invention relates to novel conjugated polymers containing one or more [1,2,5]thiadiazolo[3,4-e]isoindole-5,7-dione (tid) repeating units, to methods for their preparation and educts or intermediates used therein, to polymer blends, mixtures and formulations containing them, to the use of the polymers, polymer blends, mixtures and formulations as organic semiconductors in, or for the preparation of, organic electronic (oe) devices, especially organic photovoltaic (opv) devices and organic photodetectors (opd), and to oe, opv and opd devices comprising, or being prepared from, these polymers, polymer blends, mixtures or formulations.. .
Merck Patent Gmbh


Prodrugs of substituted azaindoleoxoacetic piperazine derivatives


This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with azaindoleoxoacetyl piperazine derivatives.
Bristol-myers Squibb Company


Piperidinyl-indole derivatives complement factor b inhibitors and uses thereof


The present invention provides a compound of formula i: (i) a method for manufacturing the compounds of the invention, and its therapeutic uses as inhibitors of the complement alternative pathway, in particular of factor b. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition..
Novartis Ag


Indole and pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them


Medicinal products containing the same which are useful in treating pathologies involving a deficit in apoptosis, such as cancer, auto-immune diseases, and diseases of the immune system.. .

Inhibitor crystalline form and preparation method and use thereof


The present invention relates to a new crystalline forms of the inhibitor, 5-fluoro-3-phenyl-2-[(s)-1-(9h-purin-6-ylamino)-propyl]-3h-quinazoline-4-one; the new crystalline form, compared to known forms, has one or more improved properties. The present invention also relates to a method for preparing a new crystalline form of 5-fluoro-3-phenyl-2-[(s)-1-(9h-purin-6-ylamino)-propyl]-3h-quinazolin-4-one, a pharmaceutical composition thereof and a use thereof in preparation of a pharmaceutical for the treatment and/or prevention of diseases such as chronic lymphocytic leukemia and indolent non-hodgkin's lymphoma..
Hangzhou Pushai Pharmaceutical Technology Co., Ltd.


Ido inhibitors


There are disclosed compounds of formula (i) that modulate or inhibit the enzymatic activity of indoleamine 2,3-di-oxygenase (ido), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or autoimmune diseases utilizing the compounds of the invention.. .
Bristol-myers Squibb Company


Immunoregulatory agents


Compounds that modulate the oxidoreductase enzyme indoleamine 2,3-dioxygenase, and compositions containing the compounds, are described herein. The use of such compounds and compositions for the treatment and/or prevention of a diverse array of diseases, disorders and conditions, including cancer- and immune-related disorders, that are mediated by indoleamine 2,3-dioxygenase is also provided..
Flexus Biosciences, Inc.


Immunoregulatory agents


Compounds that modulate the oxidoreductase enzyme indoleamine 2,3-dioxygenase, and compositions containing the compounds, are described herein. The use of such compounds and compositions for the treatment and/or prevention of a diverse array of diseases, disorders and conditions, including cancer- and immune-related disorders, that are mediated by indoleamine 2,3-dioxygenase is also provided..
Flexus Biosciences, Inc.


Method for providing stable isoindole derivatives


Method for producing an isoindole derivative, the isoindole derivative obtainable by the methods, a methods for stabilizing an isoindole derivative, and methods for detection and/or quantification of macromolecules.. .
Fraunhofer-gesellschaft Zur Foerderung Der Angewandten Forschung E.v


Ido inhibitors


There are disclosed compounds of formula (i) that modulate or inhibit the enzymatic activity of indoleamine 2,3-di-oxygenase (ido), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.. .
Bristol-myers Squibb Company


7-azaindole derivatives


Compounds of the formula (i) in which r, r1, r2 and r3 have the meanings indicated in claim 1, are inhibitors of pdk1 and cell proliferation/cell vitality and can be employed for the treatment of tumors.. .
Merck Patent Gmbh


Spiro-substituted oxindole derivatives having ampk activity


The present invention relates to compounds of formula (i), which have valuable pharmacological properties, in particular are activators of ampk and which are therefore useful in the treatment of certain disorders that can be prevented or treated by activation of this receptor. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2..
Boehringer Ingelheim International Gmbh


Modified release formulation


Drug products in the form of modified release formulations comprising the drug substance (-)-(3ar,4s,7ar)-4-hydroxy-4m-tolylethynyl-octahydro-indole-1-carboxylic acid methyl ester (afq056), as well as processes for making such drug products are provided. The drug products are useful in treating patients with parkinson's disease and exhibiting l-dopa induced dyskinesia..



Indole topics:
  • Indole Derivatives
  • Tryptophan
  • Pharmaceutically Acceptable Salt
  • Protease Inhibitors
  • Antivirals
  • Antiinfective
  • Pharmaceutical Formulations
  • Protease Inhibitor
  • Pharmaceutical Formulation
  • Immunomodulator
  • Entry Inhibitors
  • Piperazine
  • Cycloalkyl
  • Alkyl Group
  • Carbon Atoms


  • Follow us on Twitter
    twitter icon@FreshPatents

    ###

    This listing is a sample listing of patent applications related to Indole for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Indole with additional patents listed. Browse our RSS directory or Search for other possible listings.


    2.1805

    4497

    2 - 1 - 101